Another example is the peptide vaccine against spike glycoprotein with molecular docking on toll-like receptor-5 (TLR5), which can evoke early innate immune response against COVID-19 (Chakraborty et al., 2020b). The gene discussed is TLR5; the disease is COVID-19.